The role of dyslipidemia in diabetic retinopathy

Diabetes - GeneralDiabetic Complications

Diabetic Retinopathy: A Position Statement by the American Diabetes Association

Diabetes Care.

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW

doi: 10.2337/dc16-2641.

Diabetic Complications

A Review of Ranibizumab for the Treatment of Diabetic Retinopathy

Ophthalmol Ther.

Stewart MW

doi: 10.1007/s40123-017-0083-9.

Type 2 DiabetesDiabetic ComplicationsGlycemic Control

Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.

Diabetes Care.

Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Eye Study Group and the Action to Control Cardiovascular Risk in Diabetes Follow-On (ACCORDION) Study Group

doi: 10.2337/dc16-0024.

Diabetes - GeneralType 2 DiabetesDiabetic ComplicationsGlycemic Control

Semaglutide, reduction in HbA1c and the risk of diabetic retinopathy

Diabetes Obes Metab.

Vilsbøll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simó R, Helmark IC, Wijayasinghe N, Larsen M

doi: 10.1111/dom.13172.

Diabetes - GeneralType 2 DiabetesDiabetic Complications

Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis

JAMA Ophthalmol

Xie J, Ikram MK, Cotch MF, Klein B, Varma R, Shaw JE, Klein R, Mitchell P, Lamoureux EL, Wong TY

Diabetic Complications

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Diabetes Care.

Hainsworth DP, Bebu I, Aiello LP, Sivitz W, Gubitosi-Klug R, Malone J, White NH, Danis R, Wallia A, Gao X, Barkmeier AJ, Das A, Patel S, Gardner TW, Lachin JM, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group

doi: 10.2337/dc18-2308.

Diabetes - GeneralType 1 DiabetesDiabetic Complications

Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes

JAMA Ophthalmol.

Dupas B, Minvielle W, Bonnin S, Couturier A, Erginay A, Massin P, Alain Gaudric A, Tadayoni R

doi: 10.1001/

Diabetic Complications

En Face Doppler Optical Coherence Tomography Measurement of Total Retinal Blood Flow in Diabetic Retinopathy and Diabetic Macular Edema

JAMA Ophthalmol.

Lee B, Novais EA, Waheed NK, Adhi M, de Carlo TE, Cole ED, Moult EM, Choi W, Lane M, Baumal CR, Duker JS, Fujimoto JG

doi: 10.1001/

Diabetes - GeneralType 2 DiabetesDiabetic Complications

Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy

Diabetes Care.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L

doi: 10.2337/dc17-2280.

Related content

Diabetic Retinopathy: A Position Statement by the American Diabetes Association

A Review of Ranibizumab for the Treatment of Diabetic Retinopathy

Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study.

Semaglutide, reduction in HbA1c and the risk of diabetic retinopathy

Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes

En Face Doppler Optical Coherence Tomography Measurement of Total Retinal Blood Flow in Diabetic Retinopathy and Diabetic Macular Edema

Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy